CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)
Clinical trial NCT04205643 · COMPLETED
Trial details
- NCT number
- NCT04205643
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-07-07
- Enrollment
- 548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.